Nukkleus (NASDAQ:NUKK – Get Free Report) released its quarterly earnings data on Friday. The company reported ($2.02) earnings per share for the quarter, Zacks reports.
Nukkleus Price Performance
Nukkleus stock opened at $4.70 on Friday. The business has a 50 day moving average of $7.10 and a 200-day moving average of $9.17. The company has a market capitalization of $33.23 million, a P/E ratio of 0.26 and a beta of -6.49. Nukkleus has a 1 year low of $1.30 and a 1 year high of $78.32.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on NUKK shares. Wall Street Zen cut shares of Nukkleus from a “hold” rating to a “sell” rating in a report on Saturday. Weiss Ratings reissued a “sell (d)” rating on shares of Nukkleus in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.
Hedge Funds Weigh In On Nukkleus
An institutional investor recently raised its position in Nukkleus stock. UBS Group AG grew its position in shares of Nukkleus Inc. (NASDAQ:NUKK – Free Report) by 23.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 80,512 shares of the company’s stock after purchasing an additional 15,223 shares during the quarter. UBS Group AG owned about 1.14% of Nukkleus worth $564,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 12.47% of the company’s stock.
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Read More
- Five stocks we like better than Nukkleus
- Comparing and Trading High PE Ratio Stocks
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- Golden Cross Stocks: Pattern, Examples and Charts
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Under-the-Radar AI Stocks to Buy on the Dip
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
